Global Transthyretin Amyloidosis Treatment Market Set for
Dublin, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The
Stay updated with breaking news from Wild Type. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dublin, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The
Afreen Shariff, MD, MBBS, examines the surveillance and management of immunotherapy-induced adrenal insufficiency in the context of melanoma, underscoring the importance of maintaining a heightened awareness for early detection.
A panel of oncology experts explores the intricate balance between maintaining quality of life and managing toxicity in adjuvant immunotherapy for melanoma.
Afreen Shariff, MD introduces case 1 involving a 55-year-old male with Stage IIIB melanoma who develops immunotherapy-induced diabetes.
Nikhil Khushalani, MD, examines immunotherapy resistance in melanoma treatment, providing valuable insights into navigating challenges and its impact on treatment decisions.